Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.360
+0.010 (0.43%)
Oct 19, 2026, 10:11 AM EDT - Market open
Editas Medicine Employees
Editas Medicine had 87 employees as of December 31, 2025. The number of employees decreased by 159 or -64.63% compared to the previous year. That makes Editas Medicine the 32,236th largest employer in the world and 4,171st in the United States.
Employees
87
Change (1Y)
-159
Growth (1Y)
-64.63%
Revenue / Employee
$540,287
Profits / Employee
-$849,989
Market Cap
362.45M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 87 | -159 | -64.63% |
| Dec 31, 2024 | 246 | -19 | -7.17% |
| Dec 31, 2023 | 265 | 39 | 17.26% |
| Dec 31, 2022 | 226 | -38 | -14.39% |
| Dec 31, 2021 | 264 | 29 | 12.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ARS Pharmaceuticals | 200 |
| Kyverna Therapeutics | 149 |
| Scribe Therapeutics | 82 |
| Prelude Therapeutics | 79 |
| AgomAb Therapeutics NV | 62 |
| Atea Pharmaceuticals | 55 |
| Zura Bio | 40 |
| Fennec Pharmaceuticals | 35 |
EDIT News
- 5 days ago - Editas Medicine Announces Poster Presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress and Participation in Upcoming Investor Conference - GlobeNewsWire
- 10 days ago - Wells Fargo upgrades Editas Medicine after EDIT-401 study gets green light - TheFly
- 10 days ago - Editas Medicine upgraded to Overweight from Equal Weight at Wells Fargo - TheFly
- 11 days ago - Editas Medicine receives approval to initiate clinical trial of EDIT-401 - TheFly
- 11 days ago - Editas Medicine Receives Approval to Initiate First-In-Human Clinical Trial of EDIT-401 in Patients with Hyperlipidemia - GlobeNewsWire
- 25 days ago - Editas slips amid pressure on gene-editing sector after Anthropic update - TheFly
- 26 days ago - Editas Medicine upgraded to Buy at Guggenheim on EDIT-401 potential - TheFly
- 26 days ago - Editas Medicine upgraded to Buy from Neutral at Guggenheim - TheFly